Chinese researchers have developed a novel and highly efficient mitochondrial capsule transplantation therapy, achieving the safe and efficient transplantation of healthy mitochondria into cells and ...

That distinction is the most important conversation business leaders aren’t having. Nature optimizes for survival. Most ...

BioLineRx Ltd. (NASDAQ: BLRX) (TASE: BLRX), a development stage biopharmaceutical company pursuing life-changing therapies in oncology and rare diseases, today reported its audited financial results ...

On track to initiate Phase 1/2a clinical trial of GLIX1 for treatment of glioblastoma (GBM) by end of this month - - GLIX1 is positioned to potentially address unmet ...

Inequities in science affect who can publish, access funding, and drive innovation. Hear from global experts as they discuss the challenges facing the worldwide scientific community.

The lifespan of lobsters has long puzzled scientists.

Breast cancer is one of the most common cancers in women around the world. Doctors have long known that many factors can affect the risk of developing this disease. These include genetics, lifestyle, ...

Why didn’t you recommend one of the at-home kits for the person with Lynch syndrome who had a bad reaction during her colonoscopy? I don’t ever intend ...

UCLA researchers have uncovered a hidden weakness in some of the deadliest cancers, revealing a potential new strategy for targeting tumors that have long resisted treatment. Small cell neuroendocrine ...

PANTHERx ® Rare, the trusted leader and innovator in patient access and support services for personalized rare disease care, ...

Today, on Gratitude Day, we share a guest piece from HD researcher Roy Maimon that Huntington’s disease is neuroscience’s ...